Skip to end of banner
Go to start of banner

Rubrics (WIP)

Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 2 Next »

Back to all database documentation: Neurofibromatosis Research Tools Database: Documentation

Antibodies:

  • must pass schematic validation

  • epitope should be formatted using the following style:

    • if phospho-specific, have the prefix “phospho-” followed by

    • gene symbol/protein symbol e.g. “NF2” followed by

    • if phospho-specific, should label the phospho-target in parentheses with the three-character amino acid (aa) abbreviation followed by the location e.g. “(Ser2515)” followed by

    • if mutation-specific, should label the protein variant using one-character aa abbreviation eg. “(G12V)” followed by

    • if available, aa location of target in parentheses in the format of (aa START-END) e.g. “(aa 100-150)” or “(aa 507-530 N-term)”

    • examples of valid epitopes:

      • NF1

      • phospho-NF1 (Ser2515)

      • KRAS (G12V)

      • NF1 (aa 100-150)

      • NF1 (aa 507-530 N-term)

  • No labels